NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
Go back to NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System| (NASDAQ: NRXP) | Delayed: 3.76 -0.14 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.90 | 52 Week High | $ | |||
| Open | $3.80 | 52 Week Low | $ | |||
| Day High | $3.93 | P/E | N/A | |||
| Day Low | $3.72 | EPS | $ | |||
| Volume | 800,233 | |||||
